Dr. Dan Clow currently leads the Ethics an d Compliance Team at GSK. U ntil the fall of 2018 he was Director, Public Policy and Advocacy where for eight ye ars he led the team responsible for health, industrial, pharmaceutical and biologics policy at the National and Federal level s . He also oversaw the team serving as GSK’s point of contact for patient advocacy groups and professional organizations (including medical asso ciations and societies) and served GSK in several key corporate governance roles.
Dan completed his undergraduate and graduate degrees at Queen’s University, graduating with his Ph.D. in Pharm acology and Toxicology in 1988. His neuroscience research interests led him to subsequently complete a post - doctoral fellowship in the Department of Anatomy at the University of Hawai’i at Manoa. Since joining GSK (formerly Glaxo Wellcome ) in 1996, Dan has held multiple roles in the Public Affairs, Market Access , Medical and now Ethics and Compliance Divisions .